Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Saudi Arabia accelerate interest in ‘€40m+’ Barcelona midfielder

    February 20, 2026

    Explained: Why Ranji Trophy final has been shifted from Bengaluru to Hubballi?

    February 20, 2026

    Ali Partovi’s Neo looks to upend the accelerator model with low-dilution terms

    February 20, 2026
    Facebook X (Twitter) Instagram
    Select Language
    Facebook X (Twitter) Instagram
    NEWS ON CLICK
    Subscribe
    Friday, February 20
    • Home
      • United States
      • Canada
      • Spain
      • Mexico
    • Top Countries
      • Canada
      • Mexico
      • Spain
      • United States
    • Politics
    • Business
    • Entertainment
    • Fashion
    • Health
    • Science
    • Sports
    • Travel
    NEWS ON CLICK
    Home»Business & Economy»US Business & Economy»Tips from pharmacists to lower your out-of-pocket drug costs
    US Business & Economy

    Tips from pharmacists to lower your out-of-pocket drug costs

    News DeskBy News DeskJanuary 2, 2026No Comments7 Mins Read
    Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
    Tips from pharmacists to lower your out-of-pocket drug costs
    Share
    Facebook Twitter Pinterest Email Copy Link

    Even when Americans have health insurance, they can have a hard time affording the drugs they’ve been prescribed.

    About 1 in 5 U.S. adults skip filling a prescription due to its cost at least once a year, according to KFF, a health research organization. And 1 in 3 take steps to cut their prescription drug costs, such as splitting pills when it’s not medically necessary or switching to an over-the-counter drug instead of the one that their medical provider prescribed.

    As pharmacy professors who research prescription drug access, we think it’s important for Americans to know that it is possible to get prescriptions filled more affordably, as long as you know how before you go to the pharmacy.

    Cost of copays ranges widely

    When you have health insurance and have to pay for a prescription drug at the pharmacy, you’re usually covering the cost of your copay. This is the amount patients or their caregivers are expected to pay after insurance covers the rest of the tab.

    If you get your health insurance through Medicaid, the government program that covers low-income Americans and people with disabilities, you should not have to pay anything at all to obtain prescription drugs. If there is a copay, it should be low – probably less than US$5.

    And if you’re insured through Medicare, the government program that mainly covers people who are 65 and older, or get your coverage through a private health insurance company, it’s important to understand what to expect when you visit a pharmacy.

    Most private insurance companies charge US$5 to $50 for prescription drug copays. The copays are tiered based on what the drug costs. Brand-name and specialty medications have higher copays; older generics have lower copays.

    Some generic drugs and vaccines may even require no copay at all. While a copay is a flat fee, it can change over the course of the year based on whether or not you have met your deductible. The deductible is the amount of money you have to pay out of pocket before your insurance starts covering your prescriptions. Before your deductible is fully paid, you may be responsible for the full cost of your medications. After you’ve met your deductible for the year, you will only be required to pay the copay.

    As newer, more expensive drugs enter the market, cost-sharing at the pharmacy has increasingly shifted from a copay to coinsurance.

    In contrast with a flat copay, coinsurance means your insurance company will cover a certain percentage of the drug’s cost, and you’ll pay the rest. Since the patient’s share is based on a percentage of the medication’s price, coinsurance often results in higher out-of-pocket costs than copays do.

    New help for patients with Medicare coverage

    Two new government programs could help make prescription drugs more affordable for millions of older Americans.

    Starting in 2026, people who are insured through Medicare will pay no more than $2,100 out of pocket on prescription drugs over the year. That cap may be much lower than $2,100 due to a quirk in Medicare’s rules. Prescriptions filled after someone has paid the maximum allowable amount will cost them nothing at all.

    In addition, the government launched the Medicare Prescription Payment Plan in 2025. This program, which is available to people over 65, helps spread what patients spend out of pocket on prescription drugs throughout the year, making that expense more predictable and easier to budget for.

    Early data indicates that very few Americans are enrolled in the Medicare Prescription Payment Plan. Patients insured through private companies do not have similar opportunities.

    Consumers should find out if they qualify for state or federal programs on their medications.

    Coupons and discount cards

    What if you can’t afford a copay for your prescription drug?

    Before giving up on ever getting it, ask the pharmacist about your options.

    It may be worth trying to use a free online tool, such as RxAssist, sponsored by the Robert Wood Johnson Foundation, or a discount card from GoodRx, which is a publicly traded company.

    GoodRx cards are free. They help people compare local pharmacy prices and to locate coupons that make prescriptions more affordable.

    GoodRx works by searching for the lowest available price for the prescription at various pharmacies. Other copay coupons provided by the drug manufacturer may also work similarly by lowering the cost of the medication. On some occasions, the cash price at the pharmacy may actually be cheaper than the copay, and the pharmacist should be able to help you navigate these options.

    Here’s what you should know before giving GoodRx a try:

    1. GoodRx collects individual data on patients, raising significant privacy concerns.
    2. Some pharmacies do not accept GoodRx. You may have to visit more than one pharmacy to be able to activate its discounts.
    3. These cards may make the most sense for uninsured or underinsured patients, but do not always help those who have insurance because you might not get a better price. What’s more, if you use a discount card, the amount you pay may not count toward your insurance deductible for the year.

    You should weigh the caveats closely depending on your circumstance.

    Prescription assistance programs

    Prescription assistance programs provide another cost-saving tool for Americans.

    Drugmakers, nonprofits, and government agencies sponsor those programs, which help patients who are uninsured or underinsured – even if they are on Medicare – fill prescriptions either at a discount or for free.

    These programs include manufacturer-specific programs as well as charitable pharmacies like Dispensary of Hope, NOVA Scripts Central, and the Patient Advocate Foundation. Qualifying criteria vary for these programs, but typically you must have a low income and be a citizen or a legal U.S. resident.

    The Patient Access Network Foundation and RxAssist, two nonprofits that help Americans pay their medical bills, also offer helpful tools to identify programs that could work for you.

    Assistance from these programs could cut your copay or even provide a prescription drug at no cost.

    Separately, the Trump administration announced in November 2025 that a new White House prescription drug pricing program will soon begin to connect consumers to companies that have agreed to sell certain prescription drugs at a big discount.

    Many experts don’t expect the program, known as TrumpRx, to help people who have health insurance. Instead, it could be most likely to help those with no insurance at all. The new government program is slated to begin to roll out in 2026.

    Direct-to-consumer models

    Beyond coupons and assistance programs, a more radical shift is in the works: direct-to-consumer platforms and cash-payment models.

    In 2025, several manufacturers offered to sell medications directly to patients on websites and patient portals at cash prices. For example, the drug manufacturer Eli Lilly is offering its popular weight-loss medication, Zepbound, on its website.

    These websites have out-of-pocket costs that can run upward of $300 a month, making them too high for many, if not most, Americans to afford. And insurance companies have so far refused to cover them.

    To be sure, the systems underlying these programs are still being built. We believe that the Trump administration would need to make a bigger effort to make it easier for millions of Americans to be able to afford filling their prescriptions.

    Sujith Ramachandran is an associate professor of pharmacy administration at the University of Mississippi.

    Adam Pate is a clinical professor of pharmacy practice at the University of Mississippi.

    This article is republished from The Conversation under a Creative Commons license. Read the original article.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
    News Desk
    • Website

    News Desk is the dedicated editorial force behind News On Click. Comprised of experienced journalists, writers, and editors, our team is united by a shared passion for delivering high-quality, credible news to a global audience.

    Related Posts

    US Business & Economy

    Hollywood is freaking out over a viral AI video showing Brad Pitt and Tom Cruise fighting

    February 19, 2026
    US Business & Economy

    Why some United fliers will suddenly earn less for the same flights

    February 19, 2026
    US Business & Economy

    The legal fight that could force Apple to rethink iCloud design

    February 19, 2026
    US Business & Economy

    ‘Staples Baddie’ went viral. Here’s what the retailer is doing about its Gen Z employee’s internet fame

    February 19, 2026
    US Business & Economy

    Why the best problem-solvers think like jazz musicians

    February 19, 2026
    US Business & Economy

    How I Built Meaningful Success After Leaving Corporate Life

    February 19, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Don't Miss

    Saudi Arabia accelerate interest in ‘€40m+’ Barcelona midfielder

    News DeskFebruary 20, 20260

    Barcelona have centred their efforts on maintaining their squad in recent years rather than wheeling…

    Explained: Why Ranji Trophy final has been shifted from Bengaluru to Hubballi?

    February 20, 2026

    Ali Partovi’s Neo looks to upend the accelerator model with low-dilution terms

    February 20, 2026

    Danielle Smith announces a raft of referenda, seemingly designed to advance the UCP’s separatist agenda

    February 20, 2026
    Tech news by Newsonclick.com
    Top Posts

    The Roads Not Taken – Movie Reviews. TV Coverage. Trailers. Film Festivals.

    September 12, 2025

    Huey Lewis & The News, Heart And Soul

    September 12, 2025

    FNE Oscar Watch 2026: Croatia Selects Fiume o morte! as Oscar Bid

    September 12, 2025

    EU countries clash with Brussels over banking mergers – POLITICO

    July 2, 2025
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Editors Picks

    Saudi Arabia accelerate interest in ‘€40m+’ Barcelona midfielder

    February 20, 2026

    Explained: Why Ranji Trophy final has been shifted from Bengaluru to Hubballi?

    February 20, 2026

    Ali Partovi’s Neo looks to upend the accelerator model with low-dilution terms

    February 20, 2026

    Danielle Smith announces a raft of referenda, seemingly designed to advance the UCP’s separatist agenda

    February 20, 2026
    About Us

    NewsOnClick.com is your reliable source for timely and accurate news. We are committed to delivering unbiased reporting across politics, sports, entertainment, technology, and more. Our mission is to keep you informed with credible, fact-checked content you can trust.

    We're social. Connect with us:

    Facebook X (Twitter) Instagram Pinterest YouTube
    Latest Posts

    Saudi Arabia accelerate interest in ‘€40m+’ Barcelona midfielder

    February 20, 2026

    Explained: Why Ranji Trophy final has been shifted from Bengaluru to Hubballi?

    February 20, 2026

    Ali Partovi’s Neo looks to upend the accelerator model with low-dilution terms

    February 20, 2026

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Editorial Policy
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer
    • Advertise
    • Contact Us
    © 2026 Newsonclick.com || Designed & Powered by ❤️ Trustmomentum.com.

    Type above and press Enter to search. Press Esc to cancel.